Open

AWARD Peds Plus

This study is being done to see how safe a study drug is and how well it will work to help people with type 2 diabetes mellitus (T2DM).

Age & Gender

10 years ~ 17 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

United States (Nationwide)

What will be asked of you

Participants will come in for physical exams, blood draws, questionnaires, and assessments related to T2DM.

Incentives

Information provided upon request

In-person visits:
10

Phone or online visits:
3

Total length of participation:
8.5 months

Looking for Specific Volunteers

Able to participate:

Type 2 Diabetes Mellitus
Have tried other therapies to treat T2DM
Have HgA1c >7 to <11%
Have body weight > 50 kg and BMI >85%

Not eligible if:

Have Type 1 Diabetes mellitus or associated autoantibodies
Episodes of severe hypoglycemia in past six months
Have other medical conditions that could impact participating in this trial

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA

Secondary Visit Location

UNC Children's Specialty Services Raleigh
2801 Blue Ridge Rd, Raleigh, NC 27607, USA

Additional Study Information

Principal Investigator

Nina Jain
Pediatrics - Children's Research Institute

Study Type

Clinical or Medical
Interventional

Study Topics

Diabetes
Obesity

IRB Number

25-0916

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.